MetaADEDB 2.0 @ LMMD
fesoterodine
(DCCSDBARQIPTGU-HSZRJFAPSA-N)
Structure
SMILES
OCc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)OC(=O)C(C)C
Type(s)
Approved
ATC code(s)
G04BD11
Molecular Formula:
C26H37NO3
Molecular Weight:
411.577
Log P:
5.3811
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
49.77
CAS Number(s):
250214-44-9; 286930-02-7
Synonym(s)
1.
fesoterodine
2.
fesoterodine fumarate
3.
toviaz
External Link(s)
MeSHC526675
PubChem Compound6918558
ChEBI135920
CHEMBLCHEMBL1201764
DrugBankDB06702
DrugCentral4191
IUPHAR/BPS Guide to PHARMACOLOGY7473
KEGGdr:D07226
Therapeutic Target DatabaseD00BLL
ZINC1552908
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Chest discomfortFAERS: 6US FAERS
2HeadacheFAERS: 6SIDER
US FAERS
3Drug ineffectiveFAERS: 4US FAERS
4PalpitationsFAERS: 2SIDER
US FAERS
5ConstipationFAERS: 1SIDER
US FAERS
6MalaiseFAERS: 1US FAERS
7Myasthenia GravisFAERS: 1US FAERS
8VomitingFAERS: 1US FAERS
9Wrong technique in product usage processFAERS: 1US FAERS
10Abdominal PainSIDER
11Abdominal discomfortSIDER
12Alanine Aminotransferase IncreasedSIDER
13Angina PectorisSIDER
14AngioedemaSIDER
15AstheniaSIDER
16Back PainSIDER
17Benign Prostatic HyperplasiaSIDER
18Chest PainSIDER
19DermatitisSIDER
20DiverticulitisSIDER
21DizzinessSIDER
22Dry coughSIDER
23Dry skinSIDER
24DysgeusiaSIDER
25DyspepsiaSIDER
26DysuriaSIDER
27Ear and labyrinth disordersSIDER
28Electrocardiogram QT corrected intervalSIDER
29FatigueSIDER
30Feeling abnormalSIDER
31Feeling of residual urineSIDER
32FlatulenceSIDER
33Gamma-Glutamyltransferase IncreasedSIDER
34GastroenteritisSIDER
35Gastrointestinal PainSIDER
36HypersensitivitySIDER
37InfectionSIDER
38InfestationSIDER
39Irritable Bowel SyndromeSIDER
40NauseaSIDER
41Pharyngolaryngeal PainSIDER
42PruritusSIDER
43SomnolenceSIDER
44TachycardiaSIDER
45Urinary RetentionSIDER
46Urinary hesitationSIDER
47Urinary tract infectionSIDER
48UrticariaSIDER
49VertigoSIDER
50nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.